Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $21.18 down -1.94% from its previous closing price of $21.60. In other words, the price has decreased by -$1.94 from its previous closing price. On the day, 5.2 million shares were traded.
Ratios:
For a deeper understanding of BrightSpring Health Services Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 71.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.84. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 1.61 whereas as Long-Term Debt/Eq ratio is at 1.56.
On June 21, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on June 21, 2024, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 12 ’25 when Phipps Jennifer A sold 15,616 shares for $21.75 per share. The transaction valued at 339,648 led to the insider holds 230,030 shares of the business.
Nalley Lisa A sold 14,415 shares of BTSG for $313,526 on Jun 12 ’25. The insider now owns 131,150 shares after completing the transaction at $21.75 per share. On Jun 12 ’25, another insider, ROUSSEAU JON B, who serves as the insider of the company, sold 531,840 shares for $21.75 each. As a result, the insider received 11,567,520 and left with 1,184,133 shares of the company.
Valuation Measures:
As of this moment, BrightSpring’s Price-to-Earnings (P/E) ratio for their current fiscal year is 75.27, and their Forward P/E ratio for the next fiscal year is 20.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 2.20.
Stock Price History:
Over the past 52 weeks, BTSG has reached a high of $25.57, while it has fallen to a 52-week low of $10.15. The 50-Day Moving Average of the stock is 2.67%, while the 200-Day Moving Average is calculated to be 14.95%.
Shares Statistics:
A total of 175.18M shares are outstanding, with a floating share count of 79.36M. Insiders hold about 54.86% of the company’s shares, while institutions hold 52.24% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 10.0 different market analysts. The consensus estimate for the next quarter is $0.22, with high estimates of $0.31 and low estimates of $0.12.
Analysts are recommending an EPS of between $1.09 and $0.58 for the fiscal current year, implying an average EPS of $0.85. EPS for the following year is $1.02, with 11.0 analysts recommending between $1.26 and $0.75.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $2.98B this quarter.It ranges from a high estimate of $3.08B to a low estimate of $2.93B. As of the current estimate, BrightSpring Health Services Inc’s year-ago sales were $2.73BFor the next quarter, 11 analysts are estimating revenue of $3.16B. There is a high estimate of $3.23B for the next quarter, whereas the lowest estimate is $3.11B.
A total of 13 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $12.54B, while the lowest revenue estimate was $12.24B, resulting in an average revenue estimate of $12.32B. In the same quarter a year ago, actual revenue was $11.27BBased on 13 analysts’ estimates, the company’s revenue will be $13.78B in the next fiscal year. The high estimate is $14.66B and the low estimate is $13.26B.
